{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:25:48Z","timestamp":1740108348853,"version":"3.37.3"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,6,23]],"date-time":"2018-06-23T00:00:00Z","timestamp":1529712000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s10096-018-3307-6","type":"journal-article","created":{"date-parts":[[2018,6,23]],"date-time":"2018-06-23T17:25:35Z","timestamp":1529774735000},"page":"1813-1815","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Switching from CLSI to EUCAST XL susceptibility breakpoint: its implication in urinary tract infection in men"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6635-5563","authenticated-orcid":false,"given":"Amaia","family":"Aguirre-Qui\u00f1onero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. C.","family":"Lecaroz Agara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Canut Blasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,23]]},"reference":[{"key":"3307_CR1","first-page":"235","volume":"54","author":"MA Mart\u00ednez","year":"2007","unstructured":"Mart\u00ednez MA, Inglada L, Ochoa C, Villagrasa JR (2007) Assessment of antibiotic prescription in acute urinary tract infections in adults. J Inf Secur 54:235\u2013244","journal-title":"J Inf Secur"},{"key":"3307_CR2","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.eimc.2016.11.005","volume":"35","author":"M Cueto De","year":"2017","unstructured":"De Cueto M, Aliaga L, Al\u00f3s JI, Canut A, Los-Arcos I et al (2017) Executive summary of the diagnosis and treatment of urinary tract infection: guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC). Enferm Infecc Microbiol Clin 35:314\u2013320","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"3307_CR3","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1056\/NEJMcp1503950","volume":"374","author":"AJ Schaeffer","year":"2016","unstructured":"Schaeffer AJ, Nicolle LE (2016) Urinary tract infections in older men. N Engl J Med 374:562\u2013571","journal-title":"N Engl J Med"},{"key":"3307_CR4","unstructured":"CLSI. Performance standards for antimicrobial susceptibility testing. 28th ed. CLSI supplement M 100, Wayne, PA: Clinical and Laboratory Standards Institute: 2018"},{"key":"3307_CR5","first-page":"0","volume":"8","author":"The European Committee on Antimicrobial Susceptibility Testing","year":"2018","unstructured":"The European Committee on Antimicrobial Susceptibility Testing (2018) Breakpoint tables for interpretation of MICs and zone diameters. Version 8:0 \n                    http:\/\/www.eucast.org","journal-title":"Version"},{"key":"3307_CR6","first-page":"1478","volume":"72","author":"M Delgado-Valverde","year":"2017","unstructured":"Delgado-Valverde M, Valiente Mendez A, Torres E, Almirante B, G\u00f3mez-Zorrilla S et al (2017) MIC of amoxicillin\/clavulanate according to CLSI and EUCAST: discrepancies and clinical impact in patients with bloodstream infections due to Enterobacteriaceae. J Antimicrob Chemother 72:1478\u20131487","journal-title":"J Antimicrob Chemother"},{"key":"3307_CR7","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1093\/jac\/dkt218","volume":"68","author":"MA Leverstein-van Hall","year":"2013","unstructured":"Leverstein-van Hall MA, Waar K, Muilwijk J, Cohen Stuart J (2013) Consequences of switching from a fixed 2:1 ratio of amoxicillin\/clavulanate (CLSI) to a fixed concentration of clavulanate (EUCAST) for susceptibility testing of Escherichia coli. J Antimicrob Chemother 68:2636\u20132640","journal-title":"J Antimicrob Chemother"},{"key":"3307_CR8","first-page":"103","volume":"52","author":"K Gupta","year":"2011","unstructured":"Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R et al (2011) International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society of Microbiology and Infectious Diseases. Clin Pract Guide 52:103\u2013120","journal-title":"Clin Pract Guide"},{"key":"3307_CR9","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/j.1742-1241.2012.02991.x","volume":"66","author":"LS Briongos-Figuero","year":"2012","unstructured":"Briongos-Figuero LS, G\u00f3mez-Traveso T, Bachiller-Luque P, Dom\u00ednguez-Gil Gonz\u00e1lez M, G\u00f3mez-Nieto A et al (2012) Epidemiology, risk factors and comorbidity for urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)- producing enterobacteria. Int J Clin Pract 66:891\u2013896","journal-title":"Int J Clin Pract"},{"key":"3307_CR10","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1128\/AAC.20.6.800","volume":"20","author":"R Martinelli","year":"1981","unstructured":"Martinelli R, Da Silva Lopes A, De Oliveira MM, Rocha H (1981) Amoxicillin-clavulanic acid in treatment of urinary tract infection due to Gram-negative bacteria resistant to penicillin. Antimicrob Agents and Chemother 20:800\u2013802","journal-title":"Antimicrob Agents and Chemother"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-018-3307-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3307-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3307-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T19:04:50Z","timestamp":1561230290000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-018-3307-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,23]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["3307"],"URL":"https:\/\/doi.org\/10.1007\/s10096-018-3307-6","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"type":"print","value":"0934-9723"},{"type":"electronic","value":"1435-4373"}],"subject":[],"published":{"date-parts":[[2018,6,23]]},"assertion":[{"value":"10 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The lead author affirms that this manuscript is an honest, accurate, and transparent account of the study being reported that no important aspects of the study have been omitted and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Transparency declaration"}}]}}